Recordati

REC

IT0003828271

Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (32.1%). Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).

Sector

Pharmaceuticals

Calendar

2024-07-29 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR) , FTSE MIB INDEX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Recordati: An Italian mid-cap that has everything going for it

February 02, 2024 at 05:19 am EST

More Strategies

Ratings for Recordati

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

51.75 EUR

Average target price

52.64 EUR

Spread / Average Target

+1.72%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
RECORDATI	+5.98%	11.41B
ELI LILLY AND COMPANY	+55.35%	848B
NOVO NORDISK A/S	+31.64%	627B
JOHNSON & JOHNSON	-0.10%	363B
MERCK & CO., INC.	+15.47%	318B
ABBVIE INC.	+13.10%	299B
ASTRAZENECA PLC	+15.51%	243B
NOVARTIS AG	+16.72%	225B
AMGEN INC.	+16.54%	179B
PFIZER, INC.	+4.31%	167B

Other Pharmaceuticals

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-07-17 am EDT			5-day change	1st Jan Change
51.75 ^EUR	0.00%		+3.50%	+5.98%

Jul. 17	Recordati buys back own shares for EUR2 million	AN
Jul. 11	Global markets live: Tesla, Citigroup, BP, Novo Nordisk, JPMorgan...

Recordati buys back own shares for EUR2 million	Jul. 17	AN
Global markets live: Tesla, Citigroup, BP, Novo Nordisk, JPMorgan...	Jul. 11
Recordati acquires treasury shares for more than EUR3 million	Jul. 10	AN
Recordati acquires its own shares for approximately EUR3 million	Jun. 25	AN
Recordati acquires treasury shares for more than EUR4 million	Jun. 18	AN
Milan stock market continues tonic with banks, Leonardo and Recordati well, Moncler suffers	Jun. 18	RE
Recordati shares rise as investors reportedly circle CVC stake	Jun. 18	RE
Mib rises to 33,200 area; purchases on Recordati	Jun. 18	AN
Milan stock exchange, positive start with Europe driven by banks, Recordati rises	Jun. 18	RE
KKR, TPG Reportedly Express Interest in Recordati	Jun. 17	CI
Sector Update: Financial Stocks Rise Late Afternoon	Jun. 17	MT
Sector Update: Financial	Jun. 17	MT
KKR, TPG Said to be Interested in Recordati	Jun. 17	MT
KKR, TPG Interested in Italian Drugmaker Recordati, Bloomberg Reports	Jun. 17	MT
Stock markets in the green; BPER Bank leads the rises	Jun. 12	AN
Recordati buys back more than 50,000 of its own ordinary shares	Jun. 11	AN
Recordati continues buyback plan; nearly 64,000 shares purchased	Jun. 04	AN
Recordati acquires treasury shares for more than EUR3 million	May. 27	AN
Recordati Industria Chimica e Farmaceutica S.p.A. announces an Equity Buyback for 3,500,000 shares, representing 1.7% for ?85 million.	May. 26	CI
Global markets live: Microsoft, Roche, BMW, Nintendo, Nordson...	May. 21
Recordati purchased treasury shares for EUR3.8 million	May. 20	AN
Futures bullish; Mib restarts at 34,300 level	May. 10	AN
Mib up, Nexi and Prysmian good after accounts	May. 09	AN
Recordati initiates buyback for maximum EUR85 million	May. 09	AN
Transcript : Recordati Industria Chimica e Farmaceutica S.p.A., Q1 2024 Earnings Call, May 09, 2024	May. 09